1024 related articles for article (PubMed ID: 16990567)
1. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
2. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.
Dewald O; Zymek P; Winkelmann K; Koerting A; Ren G; Abou-Khamis T; Michael LH; Rollins BJ; Entman ML; Frangogiannis NG
Circ Res; 2005 Apr; 96(8):881-9. PubMed ID: 15774854
[TBL] [Abstract][Full Text] [Related]
3. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
4. MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species.
Morimoto H; Hirose M; Takahashi M; Kawaguchi M; Ise H; Kolattukudy PE; Yamada M; Ikeda U
Cardiovasc Res; 2008 Jun; 78(3):554-62. PubMed ID: 18267955
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice.
Xiang FL; Lu X; Hammoud L; Zhu P; Chidiac P; Robbins J; Feng Q
Circulation; 2009 Sep; 120(12):1065-74, 9 p following 1074. PubMed ID: 19738140
[TBL] [Abstract][Full Text] [Related]
8. Critical role for leukocyte hypoxia inducible factor-1alpha expression in post-myocardial infarction left ventricular remodeling.
Dong F; Khalil M; Kiedrowski M; O'Connor C; Petrovic E; Zhou X; Penn MS
Circ Res; 2010 Feb; 106(3):601-10. PubMed ID: 20035082
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse.
Kido M; Du L; Sullivan CC; Li X; Deutsch R; Jamieson SW; Thistlethwaite PA
J Am Coll Cardiol; 2005 Dec; 46(11):2116-24. PubMed ID: 16325051
[TBL] [Abstract][Full Text] [Related]
10. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
Du XJ; Gao XM; Kiriazis H; Moore XL; Ming Z; Su Y; Finch AM; Hannan RA; Dart AM; Graham RM
Cardiovasc Res; 2006 Sep; 71(4):735-43. PubMed ID: 16859660
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.
Obana M; Maeda M; Takeda K; Hayama A; Mohri T; Yamashita T; Nakaoka Y; Komuro I; Takeda K; Matsumiya G; Azuma J; Fujio Y
Circulation; 2010 Feb; 121(5):684-91. PubMed ID: 20100971
[TBL] [Abstract][Full Text] [Related]
12. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction.
Maekawa Y; Anzai T; Yoshikawa T; Sugano Y; Mahara K; Kohno T; Takahashi T; Ogawa S
J Am Coll Cardiol; 2004 Oct; 44(7):1510-20. PubMed ID: 15464336
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice.
Kitahara T; Takeishi Y; Harada M; Niizeki T; Suzuki S; Sasaki T; Ishino M; Bilim O; Nakajima O; Kubota I
Cardiovasc Res; 2008 Oct; 80(1):40-6. PubMed ID: 18558628
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction.
Burchfield JS; Iwasaki M; Koyanagi M; Urbich C; Rosenthal N; Zeiher AM; Dimmeler S
Circ Res; 2008 Jul; 103(2):203-11. PubMed ID: 18566343
[TBL] [Abstract][Full Text] [Related]
17. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
18. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
Wang Y; Ahmad N; Wani MA; Ashraf M
J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
[TBL] [Abstract][Full Text] [Related]
20. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
Frangogiannis NG; Dewald O; Xia Y; Ren G; Haudek S; Leucker T; Kraemer D; Taffet G; Rollins BJ; Entman ML
Circulation; 2007 Feb; 115(5):584-92. PubMed ID: 17283277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
